FOXP3 and diabetes mellitus: Low-molecular-weight dextran sulfate reduces the incidence of diabetes and even reverses diabetes in early-onset diabetic NOD mice, at least partly via increasing PD-1 expression in T cells, reducing interferon-γCD4 and CD8 T cells, and enhancing the number of FoxP3 cells (107, 108).